UniProt ID | LIN54_HUMAN | |
---|---|---|
UniProt AC | Q6MZP7 | |
Protein Name | Protein lin-54 homolog | |
Gene Name | LIN54 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 749 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the DREAM complex, a multiprotein complex that can both act as a transcription activator or repressor depending on the context. [PubMed: 17671431] | |
Protein Sequence | MEVVPAEVNSLLPEEIMDTGITLVDDDSIEAVIVSSPIPMETELEEIVNINSTGDSTATPISTEPITVYSNHTNQVAVNTTITKADSNTTVKPAFPSGLQKLGAQTPVTISANQIILNKVSQTSDLKLGNQTLKPDGQKLILTTLGKSGSPIVLALPHSQLPQAQKVTTQAQSGDAKLPPQQIKVVTIGGRPEVKPVIGVSALTPGSQLINTTTQPSVLQTQQLKTVQIAKKPRTPTSGPVITKLIFAKPINSKAVTGQTTQVSPPVIAGRVLSQSTPGTPSKTITISESGVIGSTLNSTTQTPNKIAISPLKSPNKAVKSTVQTITVGGVSTSQFKTIIPLATAPNVQQIQVPGSKFHYVRLVTATSASSSTQPVSQNPSTNTQPLQQAKPVVVNTTPVRMSVPIVSAQAVKQVVPKPINPTSQIVTTSQPQQRLIMPATPLPQIQPNLTNLPPGTVLAPAPGTGNVGYAVLPAQYVTQLQQSSYVSIASNSTFTGTSGIQTQARLPFNGIIPSESASRPRKPCNCTKSLCLKLYCDCFANGEFCNNCNCTNCYNNLEHENERQKAIKACLDRNPEAFKPKIGKGKEGESDRRHSKGCNCKRSGCLKNYCECYEAKIMCSSICKCIGCKNFEESPERKTLMHLADAAEVRVQQQTAAKTKLSSQISDLLTRPTPALNSGGGKLPFTFVTKEVAEATCNCLLAQAEQADKKGKSKAAAERMILEEFGRCLMSVINSAGKAKSDPCAMNC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 (in isoform 3) | Ubiquitination | - | 8.57 | - | |
14 (in isoform 3) | Phosphorylation | - | 61.19 | 25159151 | |
16 (in isoform 3) | Phosphorylation | - | 2.63 | 25627689 | |
23 | Acetylation | IMDTGITLVDDDSIE HHHCCCEEECCCCCE | 3.62 | 19608861 | |
28 | Acetylation | ITLVDDDSIEAVIVS CEEECCCCCEEEEEC | 29.35 | 19608861 | |
35 | Phosphorylation | SIEAVIVSSPIPMET CCEEEEECCCCCCCC | 21.19 | 26074081 | |
36 | Phosphorylation | IEAVIVSSPIPMETE CEEEEECCCCCCCCC | 18.89 | 26074081 | |
42 | Phosphorylation | SSPIPMETELEEIVN CCCCCCCCCHHHHHC | 39.35 | 26074081 | |
92 | Acetylation | ADSNTTVKPAFPSGL CCCCCCCCCCCCCHH | 28.65 | 23954790 | |
92 | Ubiquitination | ADSNTTVKPAFPSGL CCCCCCCCCCCCCHH | 28.65 | - | |
101 | Ubiquitination | AFPSGLQKLGAQTPV CCCCHHHHCCCCCCE | 54.66 | - | |
106 | Phosphorylation | LQKLGAQTPVTISAN HHHCCCCCCEEEECC | 21.13 | 25159151 | |
106 | O-linked_Glycosylation | LQKLGAQTPVTISAN HHHCCCCCCEEEECC | 21.13 | 20068230 | |
109 | O-linked_Glycosylation | LGAQTPVTISANQII CCCCCCEEEECCHHH | 15.49 | 20068230 | |
109 | Phosphorylation | LGAQTPVTISANQII CCCCCCEEEECCHHH | 15.49 | 27174698 | |
111 | O-linked_Glycosylation | AQTPVTISANQIILN CCCCEEEECCHHHHH | 16.29 | 20068230 | |
111 | Phosphorylation | AQTPVTISANQIILN CCCCEEEECCHHHHH | 16.29 | 27174698 | |
119 | Ubiquitination | ANQIILNKVSQTSDL CCHHHHHCCCCCCCC | 39.56 | - | |
121 | Phosphorylation | QIILNKVSQTSDLKL HHHHHCCCCCCCCCC | 29.38 | 27174698 | |
123 | Phosphorylation | ILNKVSQTSDLKLGN HHHCCCCCCCCCCCC | 19.39 | 27174698 | |
124 | Phosphorylation | LNKVSQTSDLKLGNQ HHCCCCCCCCCCCCE | 33.05 | 27174698 | |
127 | Ubiquitination | VSQTSDLKLGNQTLK CCCCCCCCCCCEEEC | 60.38 | - | |
134 | Ubiquitination | KLGNQTLKPDGQKLI CCCCEEECCCCCEEE | 44.44 | - | |
134 | Acetylation | KLGNQTLKPDGQKLI CCCCEEECCCCCEEE | 44.44 | 26051181 | |
136 | Acetylation | GNQTLKPDGQKLILT CCEEECCCCCEEEEE | 71.25 | 19608861 | |
136 | Ubiquitination | GNQTLKPDGQKLILT CCEEECCCCCEEEEE | 71.25 | 19608861 | |
139 | Ubiquitination | TLKPDGQKLILTTLG EECCCCCEEEEEECC | 42.92 | - | |
139 | Sumoylation | TLKPDGQKLILTTLG EECCCCCEEEEEECC | 42.92 | 28112733 | |
143 | Phosphorylation | DGQKLILTTLGKSGS CCCEEEEEECCCCCC | 17.00 | 25954137 | |
144 | Phosphorylation | GQKLILTTLGKSGSP CCEEEEEECCCCCCC | 30.02 | 25954137 | |
147 | Ubiquitination | LILTTLGKSGSPIVL EEEEECCCCCCCEEE | 55.55 | - | |
147 | Acetylation | LILTTLGKSGSPIVL EEEEECCCCCCCEEE | 55.55 | 25953088 | |
148 | Phosphorylation | ILTTLGKSGSPIVLA EEEECCCCCCCEEEE | 42.58 | 24732914 | |
150 | Phosphorylation | TTLGKSGSPIVLALP EECCCCCCCEEEEEC | 20.67 | 25159151 | |
159 | Phosphorylation | IVLALPHSQLPQAQK EEEEECHHHCCCCCC | 31.32 | 25954137 | |
166 | Ubiquitination | SQLPQAQKVTTQAQS HHCCCCCCCCCCCCC | 44.56 | - | |
168 | O-linked_Glycosylation | LPQAQKVTTQAQSGD CCCCCCCCCCCCCCC | 21.89 | 20068230 | |
195 | Ubiquitination | IGGRPEVKPVIGVSA ECCCCCCCCEEEEEE | 31.72 | - | |
195 | Acetylation | IGGRPEVKPVIGVSA ECCCCCCCCEEEEEE | 31.72 | 26051181 | |
235 | Phosphorylation | QIAKKPRTPTSGPVI EECCCCCCCCCCCCE | 39.17 | 26657352 | |
235 | O-linked_Glycosylation | QIAKKPRTPTSGPVI EECCCCCCCCCCCCE | 39.17 | 20068230 | |
237 | Phosphorylation | AKKPRTPTSGPVITK CCCCCCCCCCCCEEE | 45.78 | 28450419 | |
237 | O-linked_Glycosylation | AKKPRTPTSGPVITK CCCCCCCCCCCCEEE | 45.78 | 20068230 | |
238 | O-linked_Glycosylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 32574038 | |
238 | Phosphorylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 28450419 | |
238 | O-linked_Glycosylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 20068230 | |
243 | Phosphorylation | PTSGPVITKLIFAKP CCCCCCEEEEEEEEE | 21.74 | 28450419 | |
243 | O-linked_Glycosylation | PTSGPVITKLIFAKP CCCCCCEEEEEEEEE | 21.74 | 20068230 | |
244 | Acetylation | TSGPVITKLIFAKPI CCCCCEEEEEEEEEC | 28.58 | 19608861 | |
249 | Acetylation | ITKLIFAKPINSKAV EEEEEEEEECCCCCC | 35.36 | 19608861 | |
249 | Ubiquitination | ITKLIFAKPINSKAV EEEEEEEEECCCCCC | 35.36 | 19608861 | |
253 | O-linked_Glycosylation | IFAKPINSKAVTGQT EEEEECCCCCCCCCC | 23.78 | 20068230 | |
254 | Ubiquitination | FAKPINSKAVTGQTT EEEECCCCCCCCCCC | 42.25 | - | |
257 | Phosphorylation | PINSKAVTGQTTQVS ECCCCCCCCCCCCCC | 28.56 | 24732914 | |
260 | Phosphorylation | SKAVTGQTTQVSPPV CCCCCCCCCCCCCCE | 22.12 | 24732914 | |
261 | Phosphorylation | KAVTGQTTQVSPPVI CCCCCCCCCCCCCEE | 21.05 | 30266825 | |
264 | Phosphorylation | TGQTTQVSPPVIAGR CCCCCCCCCCEEECE | 17.42 | 23401153 | |
268 | Acetylation | TQVSPPVIAGRVLSQ CCCCCCEEECEEECC | 4.08 | 19608861 | |
268 | Ubiquitination | TQVSPPVIAGRVLSQ CCCCCCEEECEEECC | 4.08 | 19608861 | |
274 | Phosphorylation | VIAGRVLSQSTPGTP EEECEEECCCCCCCC | 21.16 | 30266825 | |
276 | Phosphorylation | AGRVLSQSTPGTPSK ECEEECCCCCCCCCC | 32.94 | 30266825 | |
276 | O-linked_Glycosylation | AGRVLSQSTPGTPSK ECEEECCCCCCCCCC | 32.94 | 20068230 | |
277 | Phosphorylation | GRVLSQSTPGTPSKT CEEECCCCCCCCCCE | 20.35 | 30266825 | |
280 | Phosphorylation | LSQSTPGTPSKTITI ECCCCCCCCCCEEEE | 26.12 | 30266825 | |
282 | Phosphorylation | QSTPGTPSKTITISE CCCCCCCCCEEEEEC | 42.12 | 30266825 | |
282 | O-linked_Glycosylation | QSTPGTPSKTITISE CCCCCCCCCEEEEEC | 42.12 | 20068230 | |
283 | Acetylation | STPGTPSKTITISES CCCCCCCCEEEEECC | 45.19 | 26051181 | |
288 | O-linked_Glycosylation | PSKTITISESGVIGS CCCEEEEECCCCCCC | 19.63 | 20068230 | |
290 | O-linked_Glycosylation | KTITISESGVIGSTL CEEEEECCCCCCCCC | 31.41 | 20068230 | |
295 | Phosphorylation | SESGVIGSTLNSTTQ ECCCCCCCCCCCCCC | 20.71 | 27080861 | |
296 | O-linked_Glycosylation | ESGVIGSTLNSTTQT CCCCCCCCCCCCCCC | 25.42 | 20068230 | |
296 | Phosphorylation | ESGVIGSTLNSTTQT CCCCCCCCCCCCCCC | 25.42 | 27080861 | |
299 | Phosphorylation | VIGSTLNSTTQTPNK CCCCCCCCCCCCCCE | 35.62 | 27251275 | |
300 | Phosphorylation | IGSTLNSTTQTPNKI CCCCCCCCCCCCCEE | 23.11 | 27080861 | |
301 | Phosphorylation | GSTLNSTTQTPNKIA CCCCCCCCCCCCEEE | 30.21 | 27080861 | |
303 | Phosphorylation | TLNSTTQTPNKIAIS CCCCCCCCCCEEEEC | 27.08 | 27080861 | |
310 | Phosphorylation | TPNKIAISPLKSPNK CCCEEEECCCCCCCH | 18.37 | 29255136 | |
313 | Ubiquitination | KIAISPLKSPNKAVK EEEECCCCCCCHHHH | 68.22 | - | |
314 | Phosphorylation | IAISPLKSPNKAVKS EEECCCCCCCHHHHC | 41.19 | 29255136 | |
321 | O-linked_Glycosylation | SPNKAVKSTVQTITV CCCHHHHCCCEEEEE | 27.49 | 20068230 | |
321 | Phosphorylation | SPNKAVKSTVQTITV CCCHHHHCCCEEEEE | 27.49 | 25332170 | |
332 | O-linked_Glycosylation | TITVGGVSTSQFKTI EEEECCCCHHHCEEE | 26.14 | 20068230 | |
333 | O-linked_Glycosylation | ITVGGVSTSQFKTII EEECCCCHHHCEEEE | 24.92 | 20068230 | |
333 | Phosphorylation | ITVGGVSTSQFKTII EEECCCCHHHCEEEE | 24.92 | 25332170 | |
344 | O-linked_Glycosylation | KTIIPLATAPNVQQI EEEEEECCCCCEEEE | 50.78 | 20068230 | |
344 | Phosphorylation | KTIIPLATAPNVQQI EEEEEECCCCCEEEE | 50.78 | 25332170 | |
357 | Acetylation | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 19608861 | |
357 | Ubiquitination | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 19608861 | |
357 | Sumoylation | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 28112733 | |
371 | Phosphorylation | VTATSASSSTQPVSQ EEEECCCCCCCCCCC | 36.80 | - | |
397 | Phosphorylation | AKPVVVNTTPVRMSV CCCEEEECCCCCCCC | 22.37 | 27732954 | |
398 | Phosphorylation | KPVVVNTTPVRMSVP CCEEEECCCCCCCCC | 18.00 | 25159151 | |
413 | Ubiquitination | IVSAQAVKQVVPKPI EEEHHHHHCCCCCCC | 40.15 | - | |
418 | Ubiquitination | AVKQVVPKPINPTSQ HHHCCCCCCCCCCCC | 47.09 | - | |
418 | Acetylation | AVKQVVPKPINPTSQ HHHCCCCCCCCCCCC | 47.09 | 26051181 | |
429 | O-linked_Glycosylation | PTSQIVTTSQPQQRL CCCCEEECCCCCCEE | 17.92 | 20068230 | |
430 | O-linked_Glycosylation | TSQIVTTSQPQQRLI CCCEEECCCCCCEEE | 30.42 | 20068230 | |
430 | Phosphorylation | TSQIVTTSQPQQRLI CCCEEECCCCCCEEE | 30.42 | 26714015 | |
435 | Methylation | TTSQPQQRLIMPATP ECCCCCCEEECCCCC | 22.42 | - | |
515 | Phosphorylation | PFNGIIPSESASRPR CCCCCCCCCCCCCCC | 33.50 | 28555341 | |
529 | Ubiquitination | RKPCNCTKSLCLKLY CCCCCCCHHHHHHHH | 43.56 | - | |
569 | Ubiquitination | NERQKAIKACLDRNP HHHHHHHHHHHHCCH | 37.60 | - | |
580 | Ubiquitination | DRNPEAFKPKIGKGK HCCHHHHCCCCCCCC | 53.07 | - | |
580 | Acetylation | DRNPEAFKPKIGKGK HCCHHHHCCCCCCCC | 53.07 | 26051181 | |
582 | Ubiquitination | NPEAFKPKIGKGKEG CHHHHCCCCCCCCCC | 65.76 | - | |
608 | Ubiquitination | CKRSGCLKNYCECYE CCCCCCCHHHHHHHH | 50.36 | - | |
635 | Phosphorylation | GCKNFEESPERKTLM CCCCCCCCCCHHHHH | 25.51 | 23401153 | |
639 | Sumoylation | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | - | |
639 | Sumoylation | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | 28112733 | |
639 | Ubiquitination | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | - | |
640 | Phosphorylation | EESPERKTLMHLADA CCCCCHHHHHHHHHH | 35.22 | 24719451 | |
659 | Sumoylation | VQQQTAAKTKLSSQI HHHHHHHHHHHHHHH | 43.67 | 28112733 | |
661 | Sumoylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | - | |
661 | Sumoylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | 28112733 | |
661 | Ubiquitination | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | - | |
661 | Acetylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | 25953088 | |
663 | Phosphorylation | TAAKTKLSSQISDLL HHHHHHHHHHHHHHH | 23.04 | 26714015 | |
664 | Phosphorylation | AAKTKLSSQISDLLT HHHHHHHHHHHHHHH | 41.80 | 26714015 | |
667 | Phosphorylation | TKLSSQISDLLTRPT HHHHHHHHHHHHCCC | 17.99 | 28555341 | |
671 | Phosphorylation | SQISDLLTRPTPALN HHHHHHHHCCCCCCC | 41.73 | 26714015 | |
683 | Ubiquitination | ALNSGGGKLPFTFVT CCCCCCCCCCEEEEC | 57.15 | - | |
683 | Acetylation | ALNSGGGKLPFTFVT CCCCCCCCCCEEEEC | 57.15 | 26051181 | |
710 | Ubiquitination | AQAEQADKKGKSKAA HHHHHHCCCCCCHHH | 67.45 | - | |
711 | Ubiquitination | QAEQADKKGKSKAAA HHHHHCCCCCCHHHH | 72.60 | - | |
715 | Acetylation | ADKKGKSKAAAERMI HCCCCCCHHHHHHHH | 45.60 | 7365103 | |
741 | Sumoylation | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - | |
741 | Sumoylation | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - | |
741 | Ubiquitination | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LIN54_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LIN54_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LIN54_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LIN9_HUMAN | LIN9 | physical | 17531812 | |
LIN37_HUMAN | LIN37 | physical | 17531812 | |
LIN52_HUMAN | LIN52 | physical | 17531812 | |
MYBB_HUMAN | MYBL2 | physical | 17531812 | |
E2F4_HUMAN | E2F4 | physical | 17531812 | |
RBL2_HUMAN | RBL2 | physical | 17531812 | |
TFDP1_HUMAN | TFDP1 | physical | 17531812 | |
TFDP2_HUMAN | TFDP2 | physical | 17531812 | |
RBBP4_HUMAN | RBBP4 | physical | 17531812 | |
MYBA_HUMAN | MYBL1 | physical | 17531812 | |
LIN9_HUMAN | LIN9 | physical | 17671431 | |
LIN37_HUMAN | LIN37 | physical | 17671431 | |
MYBB_HUMAN | MYBL2 | physical | 17671431 | |
RBBP4_HUMAN | RBBP4 | physical | 17671431 | |
RBL2_HUMAN | RBL2 | physical | 17671431 | |
RBL1_HUMAN | RBL1 | physical | 17671431 | |
E2F4_HUMAN | E2F4 | physical | 17671431 | |
RBL2_HUMAN | RBL2 | physical | 19725879 | |
MYBB_HUMAN | MYBL2 | physical | 19725879 | |
MYBB_HUMAN | MYBL2 | physical | 25368258 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-244; LYS-249 AND LYS-357,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY. |